House and Senate appropriations leaders warn White House against NIH grant controls

NIH: The National Institutes of Health is the primary federal agency responsible for biomedical and public health research funding through competitive grants. The news centers on White House discussions of added oversight for its awards process, prompting congressional pushback over concerns of politicization. NIH continues to manage its grant portfolio under ongoing budget negotiations and administrative scrutiny. House Appropriations Committee: The House Appropriations Committee oversees federal spending bills, including those funding the Department of Health and Human Services and NIH research programs. In the current news, its leaders joined Senate counterparts in warning the White House against new political controls on NIH grant awards. The panel's top Democrat, Rep. Rosa DeLauro, publicly opposed efforts to politicize the grant-making process. Senate Appropriations Committee: The Senate Appropriations Committee manages annual funding legislation for federal agencies, with direct jurisdiction over NIH budgets and operations. Its leaders, including Chair Susan Collins and Vice Chair Patty Murray, issued statements cautioning the administration that any political review of grants contravenes congressional intent. The committee has previously rejected proposals seen as undermining merit-based scientific funding decisions. Grant Review Process: NIH awards have traditionally depended on independent scientific peer review rather than political appointee approval. Congressional Oversight: Bipartisan leaders of the appropriations committees have directly challenged White House plans for additional review layers on NIH grants. Administration Initiative: White House officials have discussed an executive order creating an external commission to assess NIH grants for alignment with presidential priorities.